The Evolving Classification of Dementia

Total Page:16

File Type:pdf, Size:1020Kb

The Evolving Classification of Dementia Cult Med Psychiatry (2011) 35:417–435 DOI 10.1007/s11013-011-9219-x OPINION The Evolving Classification of Dementia: Placing the DSM-V in a Meaningful Historical and Cultural Context and Pondering the Future of ‘‘Alzheimer’s’’ Daniel R. George • Peter J. Whitehouse • Jesse Ballenger Published online: 19 May 2011 Ó Springer Science+Business Media, LLC 2011 Abstract Alzheimer’s disease is a 100-year-old concept. As a diagnostic label, it has evolved over the 20th and 21st centuries from a rare diagnosis in younger patients to a worldwide epidemic common in the elderly, said to affect over 35 million people worldwide. In this opinion piece, we use a constructivist approach to review the early history of the terms ‘‘Alzheimer’s disease’’ and related concepts such as dementia, as well as the more recent nosological changes that have occurred in the four major editions of the Diagnostic and Statistical Manual since 1952. A critical engagement of the history of Alzheimer’s disease and dementia, specifically the evolution of those concepts in the DSM over the past 100 years, raises a number of questions about how those labels and emergent diagnoses, such as Neurocog- nitive Disorders and Mild Cognitive Impairment, might continue to evolve in the DSM-V, due for release in 2013. Keywords Alzheimer’s disease Á Dementia Á Diagnostic and Statistical Manual Á Constructivism Á Brain aging D. R. George (&) Department of Humanities, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA e-mail: [email protected] P. J. Whitehouse Department of Neurology, Case Western Reserve University, University Hospital Systems, 10900 Euclid Avenue, Cleveland, OH 44106, USA J. Ballenger Department of Science, Technology and Society, Penn State University, 201 Old Main, State College, PA 16802, USA 123 418 Cult Med Psychiatry (2011) 35:417–435 Introduction A century ago, Alzheimer’s disease (AD) was formally established as a distinct nosology in an influential German psychiatry textbook. Since then, the concept has undergone various permutations, and its ongoing evolution carries important implications for the clinical treatment and cultural placement of persons who are given the diagnosis (Herskovits 1995; Whitehouse et al. 2000; George 2010). Today, AD is said to affect 35.6 million people worldwide and 5.3 million people in the United States (Prince and Jackson 2009). By 2040, AD is predicted to affect over 80 million people worldwide, 70% of whom will reside in developing countries (Essink-Bot et al. 2002). Alzheimer’s afflicts the genders differently with more women than men being affected (Barnes et al. 2005) and serving as careers for others with the condition (Alzheimer’s Association and National Alliance for Caregiving 2004). A recent meta-analysis (Plassman et al. 2010) of existing data has failed to identify a singular causal or preventive pathway for a condition that emergently appears to be heterogeneous and age related (Whitehouse and George 2008). Such findings cast doubt on the dominant Western biomedical model of AD, which regards the condition as singular and unrelated to aging (Richards and Brayne 2010). This opinion piece provides a general constructivist overview of the multifaceted historical, social and cultural processes through which severe brain aging has been shaped into an internationally known disease category called ‘‘Alzheimer’s disease’’ over the last 100 years, particularly over the past four decades. Constructivism emphasizes the culture, history, meaning and constructed nature of medical phenomena (Gaines 1992a, b) and informs the processual framework for this analysis that views disease development as an ongoing social process without terminus (Turner 1969). First, we place the AD label in a salient historical context by describing the dominance of neurobiological approaches to brain aging that were set in motion by the discoveries of the German psychiatrist Dr. Alois Alzheimer in the early 20th century. Subsequently, we describe the evolution of the classification of Alzheimer’s-type dementia in the DSM. Finally, we consider how the concepts of AD, dementia and other related diagnoses might continue to evolve in the DSM-V, due for release in 2013. Ultimately, this article adds to the growing interpretive literature on AD (Gubrium 1986; Fox 1989; Lyman 1989; Herskovits 1995; Holstein 1997; Whitehouse et al. 2005; Ballenger 2006; Hendrie 2006; Whitehouse and George 2008) while significantly contributing to what others have identified as ‘‘the meager literature on the history of AD’’. It also provides a speculative framework for future critical inquiry on subsequent publications of the DSM, in which AD will continue to evolve. Early Terminology of Dementia While the phenomenology of dementia was first recorded in various genres of ancient Egyptian writing, a number of publications have credited the ancient Greeks with having recognized and formulated the concept of dementia (Cohen 1983; 123 Cult Med Psychiatry (2011) 35:417–435 419 Torack 1983; Mahendra 1987). Memory loss and general intellectual decline, as early symptoms of the aging process, were recognized through the ages in the writings of Aristotle, Galen, Hippocrates, Lucretius, Cicero and both the Elder Seneca and the Younger Seneca in the early Roman Empire (Berrios 1987; Karenberg and Forstl 2006). The concept of dementia—a term said to have been coined by Celsus in the first century A.D.—has long carried social implications for those so diagnosed and has been associated with reduced civilian and legal competence, as well as with entitlement to support and protection. According to the writings of Solon and Plato, mentally impaired elders were incapable of making a will and were not eligible for official civilian positions but also could not be charged with unlawful acts (Kurz and Lautenschlager 2010). Similarly, in the Roman era, the concept of dementia was used to reduce the abilities of patients to enter contracts, handle their own affairs, hold public office and be criminally responsible (Berrios 1987). Modern legal systems contain similar provisions for those diagnosed with dementia. Literally meaning ‘‘away’’ or ‘‘out’’ of ‘‘mind’’ or ‘‘reason’’ in Latin, the term ‘‘dementia’’ entered the English language from the French ‘‘de´mence’’ via the French psychiatrist Philippe Pinel (Gaines 2006), who made notable contributions to the categorization of mental disorders in the late 18th and early 19th centuries. Over the centuries, the phenomenology of dementia has been causally associated with witchcraft, moral degeneracy, bad blood and a dissipation of vital energy from the brain, among other factors (Gallagher-Thompson et al. 1997). Today’s standard reductionist framework for dementia explicitly associates the condition with individual brain pathology, and the term refers to the progressive loss of cognitive function in multiple areas: memory, attention, language and problem solving. Medical anthropologists have observed that reductionist biomedical taxonomies such as AD conceptualize illnesses as ‘‘internalizing’’ rather than ‘‘externalizing,’’ in that they give primacy to biological or physical signs that can mark a disease’s progression rather than associating etiology with psychosocial or cosmic relations (Gaines 1992a, b; Lock 2005, 2010). Prior to Dr. Alzheimer’s birth in 1864, the dominant European literature of mid- to late-nineteenth-century neuropathology reflected a more ‘‘internalizing’’ concep- tual orientation, as researchers were sensitive to the texture of the brains of the apoplectic and demented. ‘‘Cerebral softening’’ was associated with atherosclerosis and described in a language of liquefaction that united physiological, psychological and moral decay, the latter factor representing a vestigial ‘‘externalizing’’ dimension to dementia held by many scientists (Cohen 1998, p. 21). Suffering in old age was largely perceived as inevitable and natural, a fact of existence that was to be ameliorated but not eliminated (Katzman and Bick 2000). However, in the late 19th century, brain aging came to be understood increasingly as an internal biological event, as scientists began using microscopy as well as sectioning and staining techniques to note changes in the brain tissues and blood vessels of the elderly and associated this pathology with the loss of cognitive functioning (Engstrom 2007). By the beginning of the 20th century, the medical literature on dementia had come to focus almost entirely on brain pathology, and the term ‘‘organic’’ was used to demonstrate that psychopathological symptom clusters in mental disorders could be 123 420 Cult Med Psychiatry (2011) 35:417–435 associated with chronic lesions on the brain (Kurz and Lautenschlager 2010). The psychiatrist, E. E. Southard, wrote that his colleagues had begun to eschew the contribution of external factors for dementia, having found ‘‘little convincing evidence that social factors play much part [in dementia]. Whatever the causes of brain atrophy, it seems they cannot be social’’ (in Ballenger 2006, p. 19). As knowledge of brain pathology widened, the cognitive changes in old age that previous generations of researchers had resigned themselves to were now seen as having visible, specific and identifiable (with the aid of a microscope) correlates in the brain that could potentially be eliminated through greater reductionist understanding. Brain aging had crossed the threshold from the normal to the pathological, and there appeared to be good reason to replace the vague concept of ‘‘senility’’
Recommended publications
  • A Case–Control Study of Erectile Dysfunction Among Men Diagnosed with Panic Disorder
    International Journal of Impotence Research (2004) 16, 299–302 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Case Report A case–control study of erectile dysfunction among men diagnosed with panic disorder WA Blumentals1*, A Gomez-Caminero1,*, RR Brown1, V Vannappagari2 and LJ Russo1 1Worldwide Epidemiology, GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania, USA; and 2Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, Chapel Hill, North Carolina, USA The association between panic disorder and erectile dysfunction (ED) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS). The IHCIS is a fully de-identified, HIPAA compliant database and includes complete medical history for more than 17 million managed care lives; data from more than 30 US health plans, covering seven census regions; and patient demographics, including morbidity, age and gender. A total of 60 949 ED cases and 243 796 controls were included for analysis. Unconditional logistic regression analyses were first performed to assess the crude risk of ED, and adjusted risks of ED that accounted for comorbid conditions and comedications. A second set of analyses measured the crude and adjusted risks after restricting the patient population to men who were diagnosed with panic disorder at least 1 month prior to an ED diagnosis. In the first set of analyses, men with panic disorder were observed to have more than a two-fold increase in risk for ED (OR ¼ 2.29, 95% CI ¼ 2.03, 2.58). After adjusting for comorbid conditions, a 52% increase in risk of ED was observed (OR ¼ 1.52, 95% CI ¼ 1.34, 1.72).
    [Show full text]
  • Neurasthenia in a Longitudinal Cohort Study of Young Adults
    Psychological Medicine, 1994, 24, 1013-1024. Copyright © 1994 Cambridge University Press Neurasthenia in a longitudinal cohort study of young adults K. MERIKANGAS1 AND J. ANGST From the Genetic Epidemiology Research Unit, Yale University School of Medicine, New Haven, CT, USA; and Psychiatric University Hospital, Zurich, Switzerland SYNOPSIS This study examines the concept of neurasthenia in a longitudinal cohort of young adults selected from a community sample of the canton of Zurich, Switzerland. The major focus is on the validity of the case definition of neurasthenia. Close approximations of the proposed descriptive and research definitions of the ICD-10 are employed as well as the concept of'irritable weakness' as described in 1831 by Kraus (1926-1932). The prevalence of neurasthenia defined according to the ICD-10 criteria was: 1 % across 10 years and 0-9% in 1988 for a duration criterion of ^ 3 months; and 81 % across 10 years and 12% in 1988 for a duration criterion of ^ 1 month. The duration criterion of ^ 3 months appeared to be excessively restrictive to represent individuals with neurasthenia in the community. Subjects with 1 month episodes of neurasthenia exhibited sufficient differences from controls and similarities to subjects with anxiety or depressive disorders to justify a 1 month duration criterion for neurasthenia in community samples. The clinical significance of neurasthenia was indicated by the magnitude of subjective distress, and occupational and social impairment reported by the majority of the cases. Prospective assessment of the longitudinal course of neurasthenia revealed that approximately 50 % of the cases continued to exhibit this disorder at follow-up.
    [Show full text]
  • Evidence Report: Risk of Adverse Cognitive Or Behavioral Conditions
    Evidence Report: Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders Human Research Program Behavioral Health and Performance Approved for Public Release: April 11, 2016 National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas 1 CURRENT CONTRIBUTING AUTHORS: Kelley J. Slack, Ph.D. Wyle Science Technology & Engineering Thomas J. Williams, Ph.D. Wyle Science Technology & Engineering Jason S. Schneiderman, Ph.D. Wyle Science Technology & Engineering Alexandra M. Whitmire, Ph.D. Wyle Science Technology & Engineering James J. Picano, Ph.D. Universities Space Research Association PREVIOUS CONTRIBUTING AUTHORS: Lauren B. Leveton, Ph.D. NASA Johnson Space Center Lacey L. Schmidt, Ph.D. Minerva Work Solutions Camille Shea, Ph.D. Houston Police Department 2 TABLE OF CONTENTS I. PRD RISK TITLE: RISK OF ADVERSE COGNITIVE OR BEHAVIORAL CONDITIONS AND PSYCHIATRIC DISORDERS ............................................................................................. 6 II. EXECUTIVE SUMMARY .................................................................................................... 9 III. INTRODUCTION ................................................................................................................ 11 IV. EVIDENCE ........................................................................................................................... 14 A. Space Flight Evidence .................................................................................................... 17 1. Sources
    [Show full text]
  • Neurology A.N
    Postgrad Med J (1991) 67, 509 - 531 i) The Fellowship of Postgraduate Medicine, 1991 Postgrad Med J: first published as 10.1136/pgmj.67.788.509 on 1 June 1991. Downloaded from Reviews in Medicine Neurology A.N. Gale, J.M. Gibbs, A.H.V. Schapira and P.K. Thomas Department ofNeurological Science, Royal Free Hospital School ofMedicine, RowlandHill Street, London NW3 2PF, UK Introduction The past few years have seen a significant improve- gitis, Tunkel et al.' point out that the mortality has ment in our ability to diagnose and treat neuro- not changed significantly over the last 30 years but logical diseases. New imaging techniques such as the prognosis for Gram-negative meningitis has computed tomographic (CT) scanning and magne- been markedly improved by the introduction of tic resonance imaging (MRI) have had a major third generation cephalosporins. impact on the practice ofneurology. Whilst techni- In adults and older children the commonest ques such as positron emission tomography (PET) causative organisms are Neisseria meningitidis and are mainly research orientated at present, they may Streptococcus pneumoniae and the treatment of soon find wider clinical application. New electro- choice in the UK is intravenous benzyl penicillin, physiological examinations such as magnetic brain with chloramphenicol as a second line agent. In stimulation have found use in the investigation of children aged 4 months to 6 years the most likely central motor conduction pathways. The applica- organism is Haemophilus influenzae type b which copyright. tion of the techniques of molecular biology to the may be resistant to ampicillin. Initial treatment in study of neurological disease is having a profound this age group has been chloramphenicol and effect on our understanding of the mechanisms ampicillin until sensitivities are known, but Peltona underlying these diseases.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research
    The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition; controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other
    [Show full text]
  • Reviving the Diagnosis of Neurasthenia"
    Psychological Medicine, 1997, 27, 989–994. Printed in the United Kingdom # 1997 Cambridge University Press EDITORIAL Reviving the diagnosis of neurasthenia" ‘Whether or not it is worthwhile to distinguish between ‘‘neurasthenia’’ and ‘‘dysthymic disorders’’ must depend either on the demonstration that such syndromes have different social covariates, or pursue a different course, or have particular responses to treatment. Until such studies are forthcoming, the distinction seems especially insubstantial.’ (Goldberg & Bridges, 1991) Epidemiological studies now indicate that fatigue is one of the most common symptoms of ill-health in the community, primary care and other medical settings, and that syndromal diagnoses based on fatigue (including chronic fatigue and neurasthenia) are prevalent and major sources of health care utilization. Such syndromes are characterized by a combination of persistent and disabling fatigue and neuropsychological and neuromuscular symptoms (Lloyd et al. 1990; Angst & Koch, 1991; Sharpe et al. 1991; Fukuda et al. 1994). Essentially, the differences between these syndromes reflect variations in duration criteria rather than symptom constructs. Specifically, the Centers for Disease Control (CDC) defines ‘prolonged fatigue’ as a syndrome of at least 1 month’s duration, and chronic fatigue (including idiopathic and chronic fatigue syndrome – CFS) as a fatigue syndrome of at least 6 months duration (Fukuda et al. 1994). The ICD-10 classification system (World Health Organization, 1992) now includes a formal diagnosis of neurasthenia (F48.0) based on mental and physical fatigue of at least 3 months duration. Despite the current international and epidemiological interest in these disorders, DSM-IV has simply included them within the ‘Undifferentiated Somatoform Disorders – 300.81’ category (American Psychiatric Association, 1994).
    [Show full text]
  • Fatigue Syndrome: Neurasthenia Revived
    result in uneven steering.9 If the tyres are deflated or 9 Goodwill CJ. Wheelchairs. In: Goodwill Cj, Chamberlain MA, eds. Rehabilitation ofthe physically disabled adult. London: Croom Helm, 1988:701-23. punctured the brakes (which work by a plate being pushed or 10 Harris A, Cox E, Smith CRW. Handicapped and impaired in Great Bnrtain. Part 1. London: HMSO, 1971. pulled against the outer edge of the tyre) are ineffective, and 11 Platts EA. Wheelchair design -survey of users' views. Proceedings ofthe Royal Society ofMedicine hence the wheelchair may move when patients get up or sit 1974;67:414-6. 12 Abel EW. Survey of attendant propelled mobile chairs used in hospitals. Health Bull (Edinb) down, causing them to fall. 1983;41:275-7. Failure ofbrakes caused by faults in the braking mechanism 13 Bossingham DH. Wheelchairs and appliances. Clinics in Rheumatic Diseases 1981;7:395-415. 14 Jay P. Choosing the best wheelchair cushion. London: Royal Association for Disability and has been shown in almost two thirds ofhospital wheelchairs in Rehabilitation, 1984. Leeds and Wessex.47 Many wheelchair brakes are crude 15 Penn ND, Belfield PW, Young JB, Whitley AJ, Mulley GP, Mascie-Taylor BH. No more flat tvres: a trial of a tyre insert for wheelchairs. Clinical Rehabilitation (in press). devices, which work loose and need constant adjustment.6 A 16 McLaurin C. Wheelchair development, standards, progress and issues. Rehabil Res Dev quarter ofwheelchair users at find to 1986;23:48-5 1. home the brakes difficult 17 Feeney RJ. Are aids for the disabled consumer goods? In: Bray J, Wright S, eds.
    [Show full text]
  • Neurasthenia at Mengo Hospital, Uganda: a Case Study in Psychiatry and a Diagnosis, 1906–50
    The Journal of Imperial and Commonwealth History ISSN: 0308-6534 (Print) 1743-9329 (Online) Journal homepage: http://www.tandfonline.com/loi/fich20 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle To cite this article: Yolana Pringle (2016): Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50, The Journal of Imperial and Commonwealth History, DOI: 10.1080/03086534.2015.1123975 To link to this article: http://dx.doi.org/10.1080/03086534.2015.1123975 © 2016 The Author(s). Published by Taylor & Francis. Published online: 11 Jan 2016. Submit your article to this journal Article views: 66 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=fich20 Download by: [University of Cambridge] Date: 27 March 2016, At: 06:16 THE JOURNAL OF IMPERIAL AND COMMONWEALTH HISTORY, 2016 http://dx.doi.org/10.1080/03086534.2015.1123975 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle Centre for Research in the Arts, Social Sciences and Humanities (CRASSH), University of Cambridge, Cambridge, UK ABSTRACT KEYWORDS This article uses a case-study approach to examine the Psychiatry; empire; Uganda; complex and contradictory nature of diagnoses like neurasthenia; mission neurasthenia in colonial Africa. Drawing on the case notes medicine; detribalisation of European and African patients diagnosed with neurasthenia at the Church Missionary Society’s Mengo Hospital, Uganda, it argues that in practice, and outside the colonial asylum in particular, ideas about race and mental illness were more nuanced than histories of psychiatry and empire might imply.
    [Show full text]
  • Hypoactive Sexual Desire Disorder in Females
    Running head: FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 1 Female Hypoactive Sexual Desire Disorder A Summary Paper Presented to The Faculty of the Adler Graduate School ___________________ In Partial Fulfillment of the Requirements for the Degree of Master of Arts in Adlerian Counseling and Psychotherapy __________________ By: Mera Le Colling October 2011 FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 2 Abstract Hypoactive sexual desire disorder is the most prevalent sexual disorder in women, and one of the most challenging to overcome. This paper discusses the current definition for HSDD, the prevalence of HSDD in women, definitions of sexual health and sexual desire, sexual myths and HSDD, and criticisms around creating sexual norms and ideals related to HSDD. This paper will also discuss physical vs. psychological arousal in women, physical, psychological, and relational aspects of HSDD, male HSDD, an Adlerian perspective of HSDD, theories of desire, and proposed definitions of female HSDD including a proposed DSM-V revision of HSDD. Treatment options discussed include hormonal, antidepressant, herbal, CBT, and mindfulness. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 3 Acknowledgments I would like to thank Professor Jere Truer for his guidance and encouragement in the selection of my master’s project. I would also like to thank Earl Heinrich for his ongoing assistance throughout my time at Adler Graduate School. Herb Laube, as both my master’s project reader and as my instructor in many classes, did much to mold my interest in psychology and human sexuality. I also wish to acknowledge the role my family played in my education, specifically Henrietta Truh and Lois Truh, my maternal grandmother and mother.
    [Show full text]
  • Energy, Aging, and Neurasthenia
    Andersen | 47 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Abstract That there is an association between energy and aging may seem commonsensical in modern society. Nonetheless, the question of how aging came to be associated with energy is less well known. This article explores how the 19th century disease of neurasthenia became related to aging through contemporaneous ideas about productivity, energy surplus and energy dissipation based on an analysis of how a lack of energy was featured as a symptom of the disease. It examines the specific historical intersection where a lack of energy was related to a diagnosis, illustrates how aging and energy have become intrinsically tied to each other and how the focus on the productive uses of energy has antecedents in religion as well as moral economics. As aging continues to be considered a problem in modern society--in large part due to the inherent unproductivity associated with old age caused by a lack of energy--the discourses surrounding neurasthenia demonstrate how the concept of energy manifested itself in contemporaneous consciousness. Keywords: aging; disease; neurasthenia; energy Anthropology & Aging, Vol 40, No 2 (2019), pp. 48-59 ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 This work is licensed under a Creative Commons Attribution 4.0 International License. This journal is published by the University Library System of the University of Pittsburgh as part of its D-Scribe Digital Publishing Program, and is cosponsored by the University of Pittsburgh Press. Anthropology & Aging Vol 40, No 2 (2019) ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 http://anthro-age.pitt.edu Andersen | 48 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Introduction An old story often told is that the human body is a phenomenon that inevitably ages.
    [Show full text]
  • The Interesting but Confusing Phenomenon of Neurasthenia and Chronic Fatigue Syndrome
    Update Article The interesting but confusing phenomenon of neurasthenia and chronic fatigue syndrome K Y Mak 麥基恩 Summary means ‘nerves exhaustion’, thus conveying some physical problems with the body. The term ‘neurasthenia’ is rather confusing, particularly for the Chinese. It has undergone Brown, a pupil of Cullen, developed the concept of metamorphosis, and is nowadays characterised by neurasthenia at the end of the 18th century to describe unexplained persistent physical symptoms especially general functional disorders of the nervous system with chronic fatigue. It is a common presentation to primary no specific localised lesions found. Kraus in 1831 and care doctors, and these patients are frequent consumers Most in 1836 equated neurasthenia as a synonym for of health care services of various types. There is a high nervous weakness, and von Deusen wrote about the topic association with psychological distress and other some 30 years later.1 However, it was George M Beard psychiatric disorders have to be ruled out in order to who in 1867 described more than 50 symptoms, both reduce confusion. Treatment is rather non-specific, physical and mental, that can be diagnosed as though antidepressants and/or cognitive-behavioural neurasthenia. The main feature is that of unexplained therapy can be quite effective. The author recommends 2 that the term ‘eurasthenia’ be used as a layman term while chronic ‘fatigue’ and weakness. According to him, the communicating with the patient, but to use ‘chronic disorder was the exhaustion of the nervous force caused fatigue syndrome’ as a medical terminology when by environmental factors and rapid social changes in corresponding with other colleagues.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders
    The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system.
    [Show full text]